147492-65-7

Basic information

• Product Name: C22 Dihydroceramide
• Synonyms: C22 Dihydroceramide;N-[(1S,2R)-2-Hydroxy-1-(hydroxymethyl)-heptadecyl]-docosanamide
• CAS NO: 147492-65-7
• Molecular Formula: C40H81NO3
• Molecular Weight: 624.08
• Product Categories: Protein Kinase Inhibitors and Activators;Fatty Acid Derivatives & Lipids;Inhibitors
• Mol File: 147492-65-7.mol
• Article Data: 9

Chemical Properties

• Melting Point: 97-99°C
• Boiling Point: 732.2°C at 760 mmHg
• Flash Point: 396.6°C
• Appearance: /
• Density: 0.903g/cm³
• Vapor Pressure: 9.55E-25mmHg at 25°C
• Refractive Index: 1.473
• Storage Temp.: -20°C Freezer
• Solubility: Chloroform (Slightly, Heated), Methanol (Slightly, Heated)
• CAS DataBase Reference: C22 Dihydroceramide(CAS DataBase Reference)
• NIST Chemistry Reference: C22 Dihydroceramide(147492-65-7)
• EPA Substance Registry System: C22 Dihydroceramide(147492-65-7)

Safety Data

• Hazardous Substances Data: 147492-65-7(Hazardous Substances Data)

Usage

Chemical Properties

White solid

Uses

C22 Dihydroceramide (cas# 147492-65-7) is a compound useful in organic synthesis.

InChI:InChI=1/C40H81NO3/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-26-28-30-32-34-36-40(44)41-38(37-42)39(43)35-33-31-29-27-25-23-16-14-12-10-8-6-4-2/h38-39,42-43H,3-37H2,1-2H3,(H,41,44)/t38-,39+/m0/s1

Upstream product

• 27888-44-4 (2S,3R)-N-(docosanoate)-1,3-dihydroxy-2-amino-octadeca-4-(E)-ene 

Relevant articles and documents

METHOD OF ISOLATING SPHINGOLIPIDS FROM CORDYCEPS AND THEIR USE

A method of isolating at least one sphingolipid portion selected from a sphingoid base portion, a ceramide portion, a glycosphingolipid portion or a phosphosphingolipid portion from Cordyceps, in particular from wild-type Cordyceps, allows for obtaining sphingolipid portions having an increased amount of one of sphingoid bases, ceramides, glycosphingolipids or phosphosphingolipids. The sphingolipid portions isolated contained significant amounts of sphingolipids not reported so far, and possess exceptional immunosuppressive activities. A method of treating a subject suffering from an inflammatory disease like an autoimmune disease or an allergic disease includes administering sphingolipids isolated from Cordyceps, in particular from wild-type Cordyceps. A method of treating a subject suffering from an inflammatory disease includes administering certain sphingolipids to the subject. Still further in accordance with the present invention is a composition, in particular a pharmaceutical composition comprising at least one sphingolipid portion.

COSMETIC COMPOSITION COMPRISING AT LEAST ONE CATIONIC COPOLYMER AND AT LEAST ONE ANIONIC ASSOCIATIVE POLYMER AND COSMETIC TREATMENT PROCESSES USING SAID COMPOSITION

The disclosure relates to novel cosmetic compositions comprising, in a cosmetically acceptable medium: (i) at least one cationic polymer which are produced by polymerization of a mixture of monomers comprising: a) at least one vinyl monomer substituted with at least one amino group, b) at least one hydrophobic nonionic vinyl monomer, c) at least one associative vinyl monomer, and e) at least one hydroxylated nonionic vinyl monomer, and (ii) at least one anionic associative polymers.

Dyeing processes comprising at least one multi-carbosite, multi-group coupling agent for wash-protecting the color of artificially dyed keratin fibers

Disclosed herein is a cosmetic process for wash-protecting the color of artificially dyed keratin fibers, comprising applying to the keratin fibers at least one composition comprising at least one multi-carbosite, multi-group coupling agent, the coupling agent being an electrophilic hydrocarbon-based compound comprising neither an aldehyde group, nor a carboxylic acid group, nor a formol-generating group, the coupling agent comprising at least two identical reactive groups, the reactive groups not being carried by the same atom, if said atom is a carbon atom, and the coupling agent having a molecular weight of less than 500 g/mol.